獸醫腫瘤學市場：治療（化療、免疫療法、放射療法）、動物類型（狗、貓）、癌症類型-俄烏衝突和高通貨膨脹-全球預測2023-2030

全球獸醫腫瘤市場預計將以 9.18% 的複合年增長率大幅增長，到 2023 年達到 7400 萬美元，預計到 2030 年將達到驚人的 1.3708 億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球動物腫瘤市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細資訊。

4.市場趨勢：全面了解俄羅斯-烏克蘭衝突和高通脹。

5.競爭評估和資訊：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.動物腫瘤的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球動物腫瘤學市場的影響有哪些障礙和影響？

3. 在預測期內，應投資全球動物腫瘤市場的哪些產品/細分市場/應用/領域？

4.全球動物腫瘤市場的競爭策略是什麼？

5.全球動物腫瘤市場的技術趨勢和監管框架是什麼？

6.全球獸用腫瘤市場主要廠商的市場份額是多少？

7. 哪些形式和戰略舉措被認為適合進入全球獸醫腫瘤學市場？

目錄

第 1 章前言

第 2 章研究方法

第 3 章執行摘要

第 4 章市場概述

第 5 章市場洞察

• 市場動態
  • 促進因素
    • 寵物癌症發病率上升
    • 加大癌症治療研發力度
    • 寵物治療技術的進步
  • 抑制因素
    • 寵物癌症治療費用高昂
  • 機會
    • 提高對獸醫癌症治療的認識
    • 政府的首選舉措
  • 課題
    • 用於治療寵物癌症的藥物的副作用
• 市場趨勢
• 新冠肺炎 (COVID-19) 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通脹的累積影響
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 監管框架
• 客戶定制

第 6 章按治療劃分的獸醫腫瘤學市場

• 化療
• 免疫治療
• 放射科
• 手術

第 7 章按動物類型劃分的獸醫腫瘤學市場

• 犬類
• 貓科動物

第 8 章按癌症類型劃分的獸醫腫瘤學市場

• 淋巴瘤
• 乳腺癌和鱗狀細胞癌
• 肥大細胞癌

第 9 章美洲獸醫腫瘤市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第 10 章亞太獸醫腫瘤市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第 11 章歐洲、中東和非洲的獸醫腫瘤市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 意大利
• 荷蘭
• 尼日利亞
• 挪威
• 波蘭
• 卡塔爾
• 俄羅斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合酋長國
• 英國

第 12 章競爭態勢

• FPNV定位矩陣
• 市場份額分析：主要公司
• 競爭情景分析：主要公司

第 13 章上市公司名單

第 14 章附錄

• 討論指南
• 關於許可證和價格

The Global Veterinary Oncology Market is forecasted to grow significantly, with a projected USD 74.00 million in 2023 at a CAGR of 9.18% and expected to reach a staggering USD 137.08 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Veterinary Oncology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Veterinary Oncology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapy, market is studied across Chemotherapy, Immunotherapy, Radiology, and Surgery. The Radiology is projected to witness significant market share during forecast period.

Based on Animal Type, market is studied across Canine and Feline. The Feline is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer. The Mast Cell Cancer is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.99% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Veterinary Oncology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Veterinary Oncology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Oncology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Oncology Market?

4. What is the competitive strategic window for opportunities in the Global Veterinary Oncology Market?

5. What are the technology trends and regulatory frameworks in the Global Veterinary Oncology Market?

6. What is the market share of the leading vendors in the Global Veterinary Oncology Market?

7. What modes and strategic moves are considered suitable for entering the Global Veterinary Oncology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Veterinary Oncology Market, by Therapy, 2022 vs 2030
• 4.3. Veterinary Oncology Market, by Animal Type, 2022 vs 2030
• 4.4. Veterinary Oncology Market, by Cancer Type, 2022 vs 2030
• 4.5. Veterinary Oncology Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
    • 5.1.1.2. Growing R&D Initiatives for Cancer Management
    • 5.1.1.3. Technological Advancement in Pet Treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Pet Cancer Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
    • 5.1.3.2. Favourable Government Initiatives
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Veterinary Oncology Market, by Therapy

• 6.1. Introduction
• 6.2. Chemotherapy
• 6.3. Immunotherapy
• 6.4. Radiology
• 6.5. Surgery

7. Veterinary Oncology Market, by Animal Type

• 7.1. Introduction
• 7.2. Canine
• 7.3. Feline

8. Veterinary Oncology Market, by Cancer Type

• 8.1. Introduction
• 8.2. Lymphoma
• 8.3. Mammary and Squamous Cell Cancer
• 8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Oncology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Oncology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

1. AB Science SA

2. C.H. Boehringer Sohn AG & Ko. KG

3. Ceva Sante Animale S.A.

4. Covetrus, Inc.

5. Elanco Animal Health Incorporated

6. Fidocure

7. IDEXX Laboratories, Inc.

8. Karyopharm Therapeutics

9. Morphogenesis, Inc.

10. Nippon Zenyaku Kogyo Co., Ltd.

11. PetCure Oncology LLC

12. PharmAust Limited

13. Regeneus Ltd.

14. Rhizen Pharmaceuticals AG

15. Varian Medical Systems, Inc.

16. VetDC, Inc.

17. Vetoquinol S.A.

18. Virbac SA

LIST OF FIGURES

• FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY ONCOLOGY MARKET SIZE, 2022 VS 2030
• FIGURE 3. VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2022 VS 2030 (%)
• FIGURE 5. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2030 (%)
• FIGURE 6. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
• FIGURE 7. VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. VETERINARY ONCOLOGY MARKET DYNAMICS
• FIGURE 9. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 5. VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 10. VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 13. VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 27. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 44. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 46. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 47. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 99. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 110. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 111. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 113. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 114. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 143. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. VETERINARY ONCOLOGY MARKET LICENSE & PRICING